MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'constellation'. Sat, 03 Sep 2011 02:41:16 +0100 http://www.medworm.com/index.php?rid=4436942&cid=t_202147_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FFoD7p_TQbwc%2F Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone? And here is our regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Qforma hired Ted Pine as vice president of business development. He was previously vice president of sales at openQ, which markets programs for key opinion leader management and compliance, and was senior director of strategic accounts at Leade... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=4436942 Fri, 04 Feb 2011 13:11:44 +0100 4436942 http://www.medworm.com/index.php?rid=3231451&cid=t_202147_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FSKg9nI2GOcY%2F By Tad DeHavenThe president’s new budget proposes to end NASA’s Constellation program, a Bush initiative intended to put humans back on the moon by 2020. But Obama’s $3.8 trillion budget still goes to the moon figuratively — if you stacked 3.8 trillion $1 bills, the pile would reach the moon with 20,000 miles to spare! The president’s proposal to end the Constellation isn’t sitting well with those members of Congress who enjoy large NASA spending in their districts. From the Washington Post: “The president’s proposed NASA budget begins the death march for the future of U.S. human spaceflight,” Sen. Richard C. Shelby (R-Ala.) said Monday. “If this budget is enacted, NASA will no longer be an agency of innovation and hard science. It will be the agency of ... Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=3231451 Tue, 02 Feb 2010 12:11:05 +0100 3231451 http://www.medworm.com/index.php?rid=2963309&cid=t_202147_137_f&fid=35426&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FTheAlzheimersReadingRoom%2F%7E3%2F15WB71zKhMc%2Fdimebon-contact-and-constellation.html Pfizer Inc (NYSE: PFE) and Medivation, Inc. (NASDAQ: MDVN) today announced the initiation of CONTACT and CONSTELLATION, two Phase 3 trials of the investigational drug dimebon (latrepirdine)* in patients with moderate-to-severe Alzheimer’s disease (AD).The CONTACT study will... Comments and sharing welcome. (Source: Alzheimer's Reading Room, The) Alzheimer's Reading Room, The blogs http://www.medworm.com/rss/comments.php?id=2963309 Wed, 04 Nov 2009 19:47:56 +0100 2963309 http://www.medworm.com/index.php?rid=2512393&cid=t_202147_131_f&fid=34990&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fepigeneticsnews%2F%7E3%2F6zpkGeXWgx0%2F One of the news items that was missed in April during the brief hiatus was about a new biotech outfit (Constellation Pharmaceuticals) that had raised $32 million in a series A round of funding. The company immediately drew my attention not because they were planning to develop epigenetic drug therapies for cancer, but because of their founders: David Allis, Yang Shi, and Danny Reinberg are all well-respected scientists in the epigenetics field, and their founding of the company brings an immediate legitimacy to the organization, which was no doubt helpful in the round of funding. Additionally, it probably didn’t hurt gaining the attention of Mark Levin of Third Rock Ventures, the former cofounder of Millenium Pharmaceuticals, who is now the interim CEO of Constellation. The young com... Epigenetics News blogs http://www.medworm.com/rss/comments.php?id=2512393 Tue, 02 Sep 2008 14:01:50 +0100 2512393